Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
企業コードLFCR
会社名Lifecore Biomedical Inc
上場日Feb 15, 1996
最高経営責任者「CEO」Mr. Paul Josephs
従業員数524
証券種類Ordinary Share
決算期末Feb 15
本社所在地3515 Lyman Boulevard
都市CHASKA
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号55318
電話番号19523684300
ウェブサイトhttps://www.lifecore.com/
企業コードLFCR
上場日Feb 15, 1996
最高経営責任者「CEO」Mr. Paul Josephs
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし